推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

JNCI-Journal of the National Cancer Institute

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 JNCI-J NATL CAN最新评论:under consideration后很快变成review complete是不是被拒稿了啊 (2024-11-14)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
出版社推荐:
美国化学会ACS期刊一览
IF 2.9,JCR Q2 神经系统基础研究期刊征稿中
开放获取选刊时如何避雷?点击查看干货指南!
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


JNCI-Journal of the National Cancer Institute期刊基本信息Hello,您是该期刊的第43913位访客


基本信息 登录收藏
期刊名字JNCI-Journal of the National Cancer InstituteJNCI-Journal of the National Cancer Institute

JNCI-J NATL CANCER I
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
9.0
51人评分
我要评分

声誉
10.0

影响力
8.1

速度
9.7

期刊ISSN0027-8874
微信扫码收藏此期刊
E-ISSN1460-2105
2023-2024最新影响因子
(数据来源于搜索引擎)
9.9 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:4.948
2023-2024自引率3.00%点击查看自引率趋势图
五年影响因子10.5
JCI期刊引文指标 2.15
h-index 暂无h-index数据
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
17.004.9862.556
学科分区排名百分位
大类:Medicine
小类:Oncology
Q128 / 404
大类:Medicine
小类:Cancer Research
Q121 / 230

期刊简介
The Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.
期刊官方网站http://jnci.oxfordjournals.org/
期刊投稿网址
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足JNCI-Journal of the National Cancer Institute的语言要求,还能让JNCI-Journal of the National Cancer Institute编辑和审稿人得到更好的审稿体验,让稿件最大限度地被JNCI-Journal of the National Cancer Institute编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式JOURNALS DEPT, 2001 EVANS RD, CARY, USA, NC, 27513
出版商Oxford University Press
涉及的研究方向ONCOLOGY-
出版国家或地区UNITED STATES
出版语言English
出版周期
出版年份0
年文章数 183点击查看年文章数趋势图
Gold OA文章占比31.79%
研究类文章占比:
文章 ÷(文章 + 综述)
94.54%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ128/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ123/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 4区1区3区
ONCOLOGY
肿瘤学
2区4区1区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区1区3区
ONCOLOGY
肿瘤学
4区2区1区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区4区
ONCOLOGY
肿瘤学
3区2区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0027-8874%5BISSN%5D
平均审稿速度网友分享经验:

平均录用比例网友分享经验:
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在JNCI-Journal of the National Cancer Institute顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 JNCI-Journal of the National Cancer Institute期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 JNCI-Journal of the National Cancer Institute中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
JNCI-Journal of the National Cancer Institute上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE683351
    BIOMATERIALS570847
    BIOMEDICINE & PHARMACOTHERAPY556699
    Frontiers in Pharmacology520278
    Journal of Materials Chemistry B514854
    Frontiers in Immunology497513
    COMPUTERS IN BIOLOGY AND MEDICINE480216
    JOURNAL OF ETHNOPHARMACOLOGY471167
    COLLOIDS AND SURFACES B-BIOINTERFACES441271
    Frontiers in Oncology440138
  •  

    JNCI-Journal of the National Cancer Institute JNCI-Journal of the National Cancer Institute
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer

    Author: Yu, Huichuan; Wang, Xiaolin; Bai, Liangliang; Tang, Guannan; Carter, Kelly T.; Cui, Ji; Huang, Pinzhu; Liang, Li; Ding, Yanqing; Cai, Muyan; Huang, Meijin; Liu, Huanliang; Cao, Guangwen; Gallinger, Steven; Pai, Rish K.; Buchanan, Daniel D.; Win, Aung Ko; Newcomb, Polly A.; Wang, Jianping; Grady, William M.; Luo, Yanxin
    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 1, pp. 52-61. DOI: 10.1093/jnci/djac183
        PubMed      DOI
    2.Design and reporting of phase III oncology trials with prospective biomarker validation

    Author: Liang, Fei; Peng, Ling; Wu, Zhengyu; Giamas, Georgios; Stebbing, Justin
    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 2, pp. 174-180. DOI: 10.1093/jnci/djac210
        PubMed      DOI
    3.Ultra-processed food consumption and risk of colorectal cancer precursors: results from 3 prospective cohorts

    Author: Hang, Dong; Wang, Lu; Fang, Zhe; Du, Mengxi; Wang, Kai; He, Xiaosheng; Khandpur, Neha; Rossato, Sinara L.; Wu, Kana; Hu, Zhibin; Shen, Hongbing; Ogino, Shuji; Chan, Andrew T.; Giovannucci, Edward L.; Zhang, Fang Fang; Song, Mingyang
    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 2, pp. 155-164. DOI: 10.1093/jnci/djac221
        PubMed      DOI
    4.Risk prediction models for endometrial cancer: development and validation in an international consortium

    Author: Shi, Joy; Kraft, Peter; Rosner, Bernard A.; Benavente, Yolanda; Black, Amanda; Brinton, Louise A.; Chen, Chu; Clarke, Megan A.; Cook, Linda S.; Costas, Laura; Dal Maso, Luigino; Freudenheim, Jo L.; Frias-Gomez, Jon; Friedenreich, Christine M.; Garcia-Closas, Montserrat; Goodman, Marc T.; Johnson, Lisa; La Vecchia, Carlo; Levi, Fabio; Lissowska, Jolanta; Lu, Lingeng; McCann, Susan E.; Moysich, Kirsten B.; Negri, Eva; O'Connell, Kelli; Parazzini, Fabio; Petruzella, Stacey; Polesel, Jerry; Ponte, Jeanette; Rebbeck, Timothy R.; Reynolds, Peggy; Ricceri, Fulvio; Risch, Harvey A.; Sacerdote, Carlotta; Setiawan, Veronica W.; Shu, Xiao-Ou; Spurdle, Amanda B.; Trabert, Britton; Webb, Penelope M.; Wentzensen, Nicolas; Wilkens, Lynne R.; Xu, Wang Hong; Yang, Hannah P.; Yu, Herbert; Du, Mengmeng; De Vivo, Immaculata
    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djad014
        PubMed      DOI
    5.Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions

    Author: Lam, W. K. Jacky; King, Ann D.; Miller, Jacob A.; Liu, Zhiwei; Yu, Kelly J.; Chua, Melvin L. K.; Ma, Brigette B. Y.; Chen, Ming Yuan; Pinsky, Benjamin A.; Lou, Pei-Jen; Woo, John K. S.; Hsu, Wan-Lun; Simon, Julia; Doolan, Denise L.; Waterboer, Tim; Hui, Edwin P.; Li, Hui; Tsang, Raymond K.; Wong, Kenneth C. W.; Goh, Julian P.; Vlantis, Alexander C.; Ai, Qi Yong; Wong, Lun M.; Abdullah, Victor; Lin, Jin Ching; Chen, Chien-Jen; Pfeiffer, Ruth M.; Le, Quynh-Thu; Lee, Anne W. M.; Ji, Mingfang; Cao, Sumei; Ma, Jun; Chan, Anthony T. C.; Chan, K. C. Allen; Hildesheim, Allan
    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 4, pp. 355-364. DOI: 10.1093/jnci/djad012
        PubMed      DOI
    6.Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

    Author: Spencer, Kristen; Pappas, Leontios; Baiev, Islam; Maurer, Jordan; Bocobo, Andrea Grace; Zhang, Karen; Jain, Apurva; De Armas, Anaemy Danner; Reyes, Stephanie; Le, Tri Minh; Rahma, Osama E.; Stanton, Jennifer; DeLeon, Thomas T.; Roth, Marc; Peters, Mary Linton B.; Zhu, Andrew X.; Lennerz, Jochen K.; Iafrate, A. John; Boyhen, Kylie; VanCott, Christine; Roberts, Lewis R.; Lindsey, Stacie; Horick, Nora; Goff, Laura Williams; Mody, Kabir; Borad, Mitesh J.; Shroff, Rachna T.; Kelley, Robin Kate; Javle, Milind M.; Goyal, Lipika
    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djad046
        PubMed      DOI
    7.Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

    Author: Lambertini M1, Campbell C2, Bines J, Korde LA3, Izquierdo M4, Fumagalli D5, Del Mastro L6, Ignatiadis M1, Pritchard K7, Wolff AC8, Jackisch C9, Lang I10, Untch M11, Smith I12, Boyle F13, Xu B14, Barrios CH15, Baselga J16,17, Moreno-Aspitia A18, Piccart M1, Gelber RD19, de Azambuja E1.
    Journal: J Natl Cancer Inst. 2019 Jan 1;111(1):86-94. doi: 10.1093/jnci/djy094.
        PubMed      DOI
    8.Novel Common Genetic Susceptibility Loci for Colorectal Cancer.

    Author: Schmit SL1,2, Edlund CK2, Schumacher FR3, Gong J4, Harrison TA4, Huyghe JR4, Qu C2,4, Melas M2, Van Den Berg DJ2, Wang H5, Tring S2,6,7, Plummer SJ8, Albanes D9, Alonso MH10,11,12, Amos CI13, Anton K13, Aragaki AK4, Arndt V14, Barry EL15, Berndt SI9, Bezieau S4, Bien S16, Bloomer A1, Boehm J17, Boutron-Ruault MC18,19, Brenner H14,20,21, Brezina S22, Buchanan DD23,24,25, Butterbach K14, Caan BJ26, Campbell PT27, Carlson CS4, Castelao JE28, Chan AT29,30, Chang-Claude J31,32,33, Chanock SJ9, Cheng I34, Cheng YW35, Chin LS36, Church JM37, Church T38, Coetzee GA39, Cotterchio M40, Cruz Correa M41, Curtis KR4, Duggan D42, Easton DF43, English D44, Feskens EJM45, Fischer R46, FitzGerald LM44,47, Fortini BK48, Fritsche LG49,50, Fuchs CS51,52, Gago-Dominguez M53,54, Gala M29, Gallinger SJ55, Gauderman WJ2, Giles GG23,44, Giovannucci EL32,56, Gogarten SM57, Gonzalez-Villalpando C58, Gonzalez-Villalpando EM59, Grady WM60, Greenson JK61, Gsur A62, Gunter M30, Haiman CA2, Hampe J63, Harlid S64, Harju JF46, Hayes RB65, Hofer P62, Hoffmeister M14, Hopper JL66, Huang SC2, Huerta JM67, Hudson TJ68,69, Hunter DJ70, Idos GE2, Iwasaki M71, Jackson RD72, Jacobs EJ27, Jee SH73, Jenkins MA23, Jia WH74, Jiao S4, Joshi AD30,70, Kolonel LN75, Kono S22, Kooperberg C4, Krogh V76, Kuehn T77, Küry S78, LaCroix A4, Laurie CA57, Lejbkowicz F1, Lemire M69, Lenz HJ2,79, Levine D57, Li CI80, Li L81, Lieb W82, Lin Y4, Lindor NM83, Liu YR84, Loupakis F35, Lu Y85, Luh F86, Ma J87, Mancao C88, Manion FJ46, Markowitz SD89, Martin V90, Matsuda K91, Matsuo K92,93, McDonnell KJ2, McNeil CE2, Milne R23,44, Molina AJ11,94, Mukherjee B46, Murphy N95, Newcomb PA4, Offit K96, Omichessan H18,19, Palli D97, Cotoré JPP98, Pérez-Mayoral J99, Pharoah PD100, Potter JD4, Qu C2,4, Raskin L85,91, Rennert G86,101,102, Rennert HS86,101, Riggs BM1, Schafmayer C103, Schoen RE104, Sellers TA1, Seminara D105, Severi G18,106, Shi W107, Shibata D108, Shu XO85,91, Siegel EM1, Slattery ML109, Southey M24, Stadler ZK96,110, Stern MC2, Stintzing S111, Taverna D112, Thibodeau SN113, Thomas DC2, Trichopoulou A114, Tsugane S2,6,7, Ulrich CM17, van Duijnhoven FJB45, van Guelpan B, Vijai J96, Virtamo J115, Weinstein SJ9, White E4, Win AK23, Wolk A116, Woods M117, Wu AH2, Wu K118, Xiang YB119, Yen Y35,120, Zanke BW121,122, Zeng YX74, Zhang B123, Zubair N4, Kweon SS124,125, Figueiredo JC126,127, Zheng W85,91, Marchand LL5, Lindblom A128, Moreno V10,11,12, Peters U129, Casey G8, Hsu L4, Conti DV2, Gruber SB2,79.
    Journal: J Natl Cancer Inst. 2019 Feb 1;111(2):146-157. doi: 10.1093/jnci/djy099.
        PubMed      DOI
    9.RE: Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis.

    Author: Chen H1, Liu Y2,3, Li P1, Zhu D2,3.
    Journal: J Natl Cancer Inst. 2019 Apr 1;111(4):435. doi: 10.1093/jnci/djy116.
        PubMed      DOI
    10.Response to H. Chen, Y. Liu, P. Li, and D. Zhu.

    Author: Yang Y1, Gao X1, Zhang M1, Zhang N1.
    Journal: J Natl Cancer Inst. 2019 Apr 1;111(4):436. doi: 10.1093/jnci/djy117.
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386173.60
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Materials61119.40
    Nature Reviews Disease Primers4876.70
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共64


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室